Benefits
Hair density and hair growth phase in men
In a 6 month placebo-controlled trial in 86 men with mild to moderate pattern hair loss, 250 mg a day raised hair density by 13.9 hairs per square cm against 0.5 on placebo, and the share of hairs in the growing phase rose from about 69% to 80%. Gains held 1 month after stopping. Bionap co-authored it and it has not been repeated.
Cyanidin anthocyanins and DHT stress on hair follicle cells
Black rice is rich in cyanidin-3-glucoside. In cell studies, cyanidin glycosides reduced DHT-driven damage and aging of dermal papilla cells, the cells that steer follicle growth, and in mice the compounds applied to the skin improved DHT-slowed hair growth. These are lab and animal results with non-oral use, not tests of ActriSave.
Antioxidant compounds from black rice and cactus flower
Both components contain antioxidant polyphenols: anthocyanins from black rice and isorhamnetin flavonoids from prickly pear flowers. Bionap also markets ActriSave for blemish-prone skin, but no study has measured antioxidant status or skin outcomes in people taking it.
Food-derived ingredients
Both source plants are foods, and no adverse events were reported in the 6 month trial. Long-term data on the concentrated extract are limited.
Mechanism of action
Anthocyanin antioxidant and anti-androgen activity
In cell studies, cyanidin-3-glucoside blocked androgen receptors and reduced DHT-induced death of dermal papilla cells, and cyanidin 3-arabinoside lowered DHT-driven mitochondrial oxidative stress and aging in these cells. Both were also tested as skin applications in mice, not taken by mouth, and neither study tested ActriSave.
Cactus-flower flavonoid contribution
Bionap states that the prickly pear flower flavonoids (isorhamnetin and derivatives) and the black rice anthocyanins have a synergistic protective effect in sebocytes and hair dermal papilla cells. This is the maker's description; none of the studies cited here tested the combination.
Proposed effect on sebocytes
Sebocytes are the oil-making cells of the skin. Bionap's claimed protective effect in these cells is the basis for marketing ActriSave for blemish-prone skin as well as hair. No skin outcome has been measured in people taking it.
Clinical trials
Randomized, double-blind, placebo-controlled trial, 250 mg a day for 6 months plus 1 month follow-up, run at Complife Italia and registered as ISRCTN17383899; two authors are Bionap employees. Not PubMed-indexed. (Cestone et al. 2023, Journal of Cosmetology & Trichology)
86 men aged 18 to 55 with Hamilton-Norwood stage II to III vertex hair loss; 82 analyzed (41 per arm).
Hair density rose by 5.5 and 13.9 hairs per square cm at 3 and 6 months on ActriSave versus 1.3 and 0.5 on placebo, with between-group differences significant. Anagen (growing) hairs rose from about 69% to 80.3% at 6 months, and the anagen to telogen ratio improved by about 86%. Results held 1 month after stopping. No adverse events were reported.